This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Julian, E.
Right arrow Articles by Luquin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Julian, E.
Right arrow Articles by Luquin, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 10 1997, 2663-2664, Vol 35, No. 10
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Detection of lipoarabinomannan antibodies in patients with newly acquired tuberculosis and patients with relapse tuberculosis

E Julian, L Matas, V Ausina and M Luquin
Departamento de Genetica y Microbiologia, Universidad Autonoma de Barcelona, Bellaterra, Spain.

A commercially available dot immunoassay that employs the lipoarabinomannan antigen was evaluated for the serologic diagnosis of tuberculosis. The test showed a high specificity (100%); however, its sensitivity was low (18.5%). Antibodies to lipoarabinomannan were detected in the sera of 7 of 71 patients with newly acquired tuberculosis and in sera of 10 of 21 patients with relapse tuberculosis. It has been shown by others that sera from patients with relapse tuberculosis had a higher concentration of antibodies and reacted with a greater variety of antigens (native culture filtrates of Mycobacterium tuberculosis H37Rv) than did sera from patients with newly acquired tuberculosis. Our data confirm the results of these previous studies as far as lipoarabinomannan is concerned. We conclude that the differences in the production of antibodies shown by the two groups of tuberculous patients (new and relapse) must be taken into account when assessing the usefulness of serologic tests for the diagnosis of tuberculosis.


This article has been cited by other articles:

  • Kameswaran, M., Shetty, K., Ray, M. K., Jaleel, M. A., Kadival, G. V. (2002). Evaluation of an In-House-Developed Radioassay Kit for Antibody Detection in Cases of Pulmonary Tuberculosis and Tuberculous Meningitis. CVI 9: 987-993 [Abstract] [Full Text]  
  • Fischer, K., Collins, H., Taniguchi, M., Kaufmann, S. H. E., Schaible, U. E. (2002). IL-4 and T Cells Are Required for the Generation of IgG1 Isotype Antibodies Against Cardiolipin. J. Immunol. 168: 2689-2694 [Abstract] [Full Text]  
  • CHAN, E. D., REVES, R., BELISLE, J. T., BRENNAN, P. J., HAHN, W. E. (2000). Diagnosis of Tuberculosis by a Visually Detectable Immunoassay for Lipoarabinomannan. Am. J. Respir. Crit. Care Med. 161: 1713-1719 [Abstract] [Full Text]